No realizar de forma sistemática la determinación de PSA a individuos asintomáticos sin antecedentes familiares de primer grado de cáncer de próstata.

Chou R, Croswell JM, Dana T, Bougastsos C, Blazina I, Fu R et al. Screening for prostate cancer: a review of the evidence for the US Preventive Services Task Force. Am Intern Med 2011;155:762-71.

Ilic D, O´Connor D, Green S, Wilt TJ. Screening for prostate cancer: an updated Cochrane Systematic Review. BJU Int 2011;107:882-91.

Lin K, Croswell JM, Koenig H, Lam C, Maltz A. Prostate-Specific Antigen-Based Screening for Prostate Cancer: An Evidence Update for the US Preventive Services Task Force. Evidence Systhesis Nº90. AHRQ Publication nº 12-05160-EF-1. Rockville MD. Agency for Healthcare Research and Quality; October 2011

Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate cancer. Cochrane Database Syst Rev 2013;31:1

Urology Group Recommends against Routine PSA Screening Cancer Discovery. August 2013.